Tower Research Capital (TRC)’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61K | Sell |
450
-468
| -51% | -$1.68K | ﹤0.01% | 4775 |
|
|
2025
Q1 | $1.97K | Sell |
918
-1,999
| -69% | -$4.3K | ﹤0.01% | 4613 |
|
|
2024
Q4 | $8.9K | Buy |
2,917
+1,274
| +78% | +$3.89K | ﹤0.01% | 3957 |
|
|
2024
Q3 | $3.79K | Sell |
1,643
-530
| -24% | -$1.22K | ﹤0.01% | 4773 |
|
|
2024
Q2 | $6.15K | Sell |
2,173
-128
| -6% | -$362 | ﹤0.01% | 4614 |
|
|
2024
Q1 | $10.2K | Buy |
2,301
+1,642
| +249% | +$7.27K | ﹤0.01% | 3732 |
|
|
2023
Q4 | $5.04K | Sell |
659
-13
| -2% | -$99 | ﹤0.01% | 4889 |
|
|
2023
Q3 | $4.86K | Buy |
672
+11
| +2% | +$80 | ﹤0.01% | 4805 |
|
|
2023
Q2 | $6.19K | Sell |
661
-286
| -30% | -$2.68K | ﹤0.01% | 4704 |
|
|
2023
Q1 | $16K | Buy |
947
+433
| +84% | +$7.32K | ﹤0.01% | 3696 |
|
|
2022
Q4 | $14K | Buy |
514
+335
| +187% | +$9.13K | ﹤0.01% | 3507 |
|
|
2022
Q3 | $9K | Buy |
179
+56
| +46% | +$2.82K | ﹤0.01% | 4654 |
|
|
2022
Q2 | $11K | Buy |
123
+15
| +14% | +$1.34K | ﹤0.01% | 4373 |
|
|
2022
Q1 | $9K | Sell |
108
-22
| -17% | -$1.83K | ﹤0.01% | 4453 |
|
|
2021
Q4 | $12K | Buy |
130
+16
| +14% | +$1.48K | ﹤0.01% | 4281 |
|
|
2021
Q3 | $23K | Buy |
114
+105
| +1,167% | +$21.2K | ﹤0.01% | 3592 |
|
|
2021
Q2 | $4K | Sell |
9
-36
| -80% | -$16K | ﹤0.01% | 4813 |
|
|
2021
Q1 | $9K | Buy |
+45
| New | +$9K | ﹤0.01% | 4422 |
|